Merck KGaA, Darmstadt, Germany, to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 19 November 2020
Merck KGaA invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event
Nov 13, 2020, 16:37 ET
DARMSTADT, Germany, Nov. 13, 2020 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany (LOCAL EXCHANGE: Deutsche Börse, US EXCHANGE: OTC), a leading science and technology company, today announced that Merck KGaA, Darmstadt, Investor Relations Director llja Doering will present at the dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference on November 19. This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to investors.
DATE: November 19, 2020
TIME: 11:00 – 11:30 AM ET
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the organization's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Participation is free of charge.
Recent Company Highlights in Q3 2020:
- Healthcare: Mavenclad® up 72% organically YoY after dip in Q2, Oncology up 7% strongly supported by early U.S. Bavencio® 1L UC ramp-up; sequential recovery of Fertility back to pre COVID-19 levels
- Life Science: Process Solutions up 27% organically, strong rebound in Research Solutions with 10% organic growth, Applied Solutions recovery slower with 4% organic growth
- Performance Materials: Semiconductor Solutions' organic growth mitigates Display and Surface decline in pandemic; Versum performance & integration ahead of plan
- Group: New ESG-targets - enhanced sustainability strategy leverages strengths and manifests company's commitment
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 57,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals and OLEDs for smartphones and televisions. In 2019, Merck KGaA, Darmstadt, Germany, generated sales of € 16.2 billion in 66 countries.
About Virtual Investor ConferencesSM
Virtual Investor Conferences is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.
A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
SOURCE dbVIC - Deutsche Bank Depositary Receipts Virtual Investor Conference
Share this article